Reversal to Normoglycemia by Treating Prediabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 158 participants.
Also called NCT07392151
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 158 participants
- Registry
-
NCT07392151
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07392151. Randomized; no masking; primary purpose prevention. Start 2026-02 (anticipated); primary completion 2029-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Reversal to Normoglycemia by Treating Prediabetes
- Condition
- Prediabetes
- Condition
- Chronic Coronary Syndrome
- Intervention (Drug)
- Intensified medical follow-up and glucose-lowering drugs
- Intervention (Other)
- No intervention
- Lead sponsor
- Michael Mæng
- Collaborator
- Aarhus University Hospital
- Collaborator
- GCP-unit at Aarhus University Hospital, Aarhus, Denmark
- Collaborator
- Department of Clinical Epidemiology, Aarhus University, DK-8200 Aarhus N, Denmark
- Collaborator
- University of Aarhus
Record details
- Record id
cardio:ct-nct07392151- Content hash
b351720761eb408eceb3c79f561e016d70da2bb965c848149e6c851b64a69c74